4l1s: Difference between revisions

Revision as of 15:04, 10 July 2013

Unreleased structure

The entry 4l1s is ON HOLD

Authors: Connelly, S., Wilson, I.A.

Description: Covalent modification of K15 by yielding the fluorescent conjugate (E)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl)benzamide

Revision as of 13:18, 3 July 2013 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,332,843 edits No edit summary ← Older edit		Revision as of 15:04, 10 July 2013 view source OCA (talk \| contribs) Bots, Bureaucrats, journal, Administrators 3,332,843 edits No edit summary Newer edit →
Line 5:		Line 5:
	Authors: Connelly, S., Wilson, I.A.		Authors: Connelly, S., Wilson, I.A.

	Description: ~~Transthyretin in complex with~~ the fluorescent conjugate (E)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl)benzamide		Description: Covalent modification of K15 by yielding the fluorescent conjugate (E)-3-(dimethylamino)-5-(4-hydroxy-3,5-dimethylstyryl)benzamide